藥物和基因遞送設備市場：按產品、非處方藥和地區分類

Drug and Gene Delivery Devices Market, By Product, By Commercialized Drugs, and By Geography

出版日期: 2025年03月26日 | 出版商:

Coherent Market Insights | 英文 155 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

藥物和基因輸送設備市場規模預計在 2025 年達到 210,800 美元，預計到 2032 年將達到 454,500 美元，2025 年至 2032 年的複合年成長率為 11.6%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	210,800美元
效能數據	2020-2024	預測期	2025-2032
預測期間：2025年至2032年的複合年成長率	11.60%	2032年價值預測	454,500美元

藥物和基因遞送裝置領域涉及藥物、基因和基因產物的開發和遞送，這些藥物、基因和基因產物最終會改變細胞、組織和生物體中的蛋白質表現和/或功能。藥物遞送裝置是透過特定給藥途徑遞送藥物的工具。而基因遞送則是將外來遺傳物質（例如DNA和RNA）引入宿主細胞的過程。

市場動態

感染疾病、心血管疾病、癌症和糖尿病等慢性疾病負擔的增加、對藥物和基因遞送裝置的需求的增加、對細胞和基因治療的資金的增加以及對基因治療的核准的增加是預計在預測期內促進全球藥物和基因遞送裝置市場成長的關鍵因素。

例如，2022年11月，Imunon, Inc. 與 Acuitas Therapeutics 達成協議，評估 Imunon 的 PLACCINE 核酸疫苗構建體與 Acuitas 專有脂質遞送技術的結合效果。根據協議，Imunon 將使用以各種 Acuitas LNP 製劑配製的載體構建體，以評估小鼠模型中的基因表現和免疫抗原性。

本研究的主要特點

本報告對全球藥物和基因輸送裝置市場進行了詳細分析，並提供了預測期 2025-2032（以 2024 年為基準年）的市場規模和年複合成長率（CAGR%）。
它還強調了各個領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
全球藥物和基因輸送裝置市場的主要企業會根據以下參數進行分析，例如公司亮點、產品系列、關鍵亮點、財務表現和策略。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球藥物和基因輸送設備市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
相關人員將透過全球藥物和基因輸送設備市場分析中使用的各種策略矩陣來做出決策。

Pfizer, Inc.
Novartis AG
Kite Pharma, Inc.
Bluebird bio, Inc.
Vericel Corporation
uniQure NV
Spark Therapeutics, Inc.
Renova Therapeutics
Orchard Therapeutics plc
Kolon Tissue Gene, Inc.
Human Stem Cell Institute
Amgen, Inc.
Dendreon Pharmaceuticals
Helixmith Co.
Bausch & Lomb Incorporated, Ltd.（ViroMed Co., Ltd.）
Becton Dickinson and Company
Castle Creek Biosciences, Inc.（Fibrocell Technologies, Inc.）

第9章章節

調查方法
關於出版商

簡介目錄

Product Code: CMI5864

Drug and Gene Delivery Devices Market is estimated to be valued at USD 210.8 Thousand in 2025 and is expected to reach USD 454.5 Thousand by 2032, growing at a compound annual growth rate (CAGR) of 11.6% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 210.8 Thousand
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	11.60%	2032 Value Projection:	USD 454.5 Thousand

The field of drug and gene delivery involves the development and delivery of drugs, genes, and/or gene products that ultimately alter protein expression and function of the cells, tissues, and living organisms. Drug delivery devices are the tools used to deliver the drug through the specific route of administration. While, gene delivery is the process of introducing foreign genetic material, such as DNA or RNA, into host cells.

Market Dynamics:

Rise in burden of chronic diseases, such as infectious disease, cardiovascular disease, cancer, and diabetes, increasing demand for drug or gene delivery devices, increasing funding for cell and gene therapies, and rise in approvals for gene therapies are major factors expected to augment the growth of the global drug and gene delivery devices market over the forecast period.

For instance, in November 2022, Imunon, Inc. and Acuitas Therapeutics signed an agreement to evaluate the combination of IMUNON's PLACCINE nucleic acid vaccine constructs formulated with Acuitas' proprietary lipid delivery technology. Under the agreement, IMUNON will evaluate administration of its vector constructs formulated in various Acuitas LNP formulations for gene expression and immunogenicity in murine models.

Key features of the study:

This report provides in-depth analysis of the global drug and gene delivery devices market, and provides market size (US$ Thousand) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global drug and gene delivery devices market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Pfizer, Inc., Novartis AG, Kite Pharma, Inc., Bluebird bio, Inc., Becton, Amgen, Inc., Vericel Corporation, uniQure N.V., Spark Therapeutics, Inc., Renova Therapeutics, Orchard Therapeutics plc, Kolon Tissue Gene, Inc., Human Stem Cell Institute, Dendreon Pharmaceuticals, Dickinson and Company, Helixmith Co., Ltd (ViroMed Co., Ltd), Bausch & Lomb Incorporated, and Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.), among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global drug and gene delivery devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug and gene delivery devices market.

Detailed Segmentation:

Global Drug and Gene Delivery Devices Market, By Product:
- Sub-retinal Injection Cannula
- Extension Tube
- Intravenous Catheter
- Sterile Insulin Syringe
- Pre-filled Syringe
- Infusion Bags
Global Drug and Gene Delivery Devices Market, By Commercialized Drugs:
- Luxturna (Drug Delivery Devices)
- Yescarta (Drug Delivery Devices)
- Zolgensma (Drug Delivery Devices)
- Kymriah (Drug Delivery Devices)
- Provenge (Drug Delivery Devices)
- Strimvelis (Drug Delivery Devices)
Global Drug and Gene Delivery Devices Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles:
- Pfizer, Inc.
- Novartis AG
- Kite Pharma, Inc.
- Bluebird bio, Inc.
- Becton Dickinson and Company
- Amgen, Inc.
- Vericel Corporation
- uniQure N.V.
- Spark Therapeutics, Inc.
- Renova Therapeutics
- Orchard Therapeutics plc
- Kolon Tissue Gene, Inc.
- Human Stem Cell Institute
- Dendreon Pharmaceuticals
- Helixmith Co., Ltd (ViroMed Co., Ltd.)
- Bausch & Lomb Incorporated
- Castle Creek Biosciences, Inc. (Fibrocell Technologies, Inc.)

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Commercialized Drugs
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Rise in burden of chronic diseases across the globe
- Stringent rules and regulations
- Increasing demand for drug and gene delivery devices
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Drug and Gene Delivery Devices Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Drug and Gene Delivery Devices Market, By Product, 2020-2032, (US$ Thousand)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Sub-retinal Injection Cannula
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Thousand)
Extension Tube
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Thousand)
Intravenous Catheter
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Thousand)
Sterile Insulin Syringe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Thousand)
Pre-filled Syringe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Thousand)
Infusion Bags
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Thousand)

6. Global Drug and Gene Delivery Devices Market, By Commercialized Drugs, 2020-2032, (US$ Thousand)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Luxturna (Drug Delivery Devices)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Thousand)
Yescarta (Drug Delivery Devices)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Thousand)
Zolgensma (Drug Delivery Devices)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Thousand)
Kymriah (Drug Delivery Devices)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Thousand)
Provenge (Drug Delivery Devices)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Thousand)
Strimvelis (Drug Delivery Devices)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Thousand)

7. Global Drug and Gene Delivery Devices Market, By Region, 2020-2032, (US$ Thousand)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Thousand)
- Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2020-2032,(US$ Thousand)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Thousand)
- Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2020-2032,(US$ Thousand)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Thousand)
- Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2020-2032,(US$ Thousand)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Thousand)
- Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2020-2032,(US$ Thousand)
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Thousand)
- Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2020-2032,(US$ Thousand)
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Thousand)
- Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2020-2032,(US$ Thousand)

8. Competitive Landscape

Pfizer, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Kite Pharma, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bluebird bio, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Vericel Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
uniQure N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Spark Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Renova Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Orchard Therapeutics plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Kolon Tissue Gene, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Human Stem Cell Institute
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Amgen, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Dendreon Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Helixmith Co.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bausch & Lomb Incorporated, Ltd. (ViroMed Co., Ltd.)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Becton Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Castle Creek Biosciences, Inc. (Fibrocell Technologies, Inc.)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views